| __timestamp | Dr. Reddy's Laboratories Limited | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 60118000 |
| Thursday, January 1, 2015 | 62786000000 | 89690000 |
| Friday, January 1, 2016 | 62427000000 | 105953000 |
| Sunday, January 1, 2017 | 62453000000 | 175062000 |
| Monday, January 1, 2018 | 65724000000 | 263389000 |
| Tuesday, January 1, 2019 | 70421000000 | 313546000 |
| Wednesday, January 1, 2020 | 80591000000 | 375181000 |
| Friday, January 1, 2021 | 86645000000 | 466491000 |
| Saturday, January 1, 2022 | 100551000000 | 577383000 |
| Sunday, January 1, 2023 | 42907000000 | 606375000 |
| Monday, January 1, 2024 | 115557000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical and biotechnology sectors, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited, a major player in the pharmaceutical industry, has seen its cost of revenue fluctuate significantly over the past decade. From 2014 to 2023, the company experienced a 105% increase, peaking in 2024. This growth reflects its expanding operations and market reach.
On the other hand, Evotec SE, a prominent biotechnology firm, has shown a steady rise in its cost of revenue, with a 900% increase from 2014 to 2023. This surge underscores its aggressive investment in research and development. However, data for 2024 is missing, leaving room for speculation on its future trajectory.
These insights highlight the contrasting strategies of these companies, offering a glimpse into their financial health and operational priorities.
Cost Insights: Breaking Down Gilead Sciences, Inc. and Evotec SE's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Evotec SE's Expenses
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Pharming Group N.V.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Evotec SE's Expenses
Cost Insights: Breaking Down Vericel Corporation and Evotec SE's Expenses
Cost of Revenue Comparison: Celldex Therapeutics, Inc. vs Evotec SE